参考文献/References:
[1]From the American Association of Neurological Surgeons (AANS),American Society of Neuroradiology (ASNR),Cardiovascular and Interventional Radiology Society of Europe (CIRSE),et al.Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke[J].Int J Stroke,2018,13(6):612-632.[2]Powers WJ,Rabinstein AA,Ackerson T,et al.Guidelines for the Early Management of Patients With Acute Ischemic Stroke:2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke:A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J].Stroke,2019,50(12):e344-e418.[3]Tsivgoulis G,Zand R,Katsanos AH,et al.Risk of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke and High Cerebral Microbleed Burden:A Meta-analysis[J].JAMA Neurol,2016,73(6):675-683.[4]Chen L,Cao S,Yang J.Argatroban plus aspirin versus aspirin in acute ischemic stroke[J].Neurol Res,2018,40(10):862-867.[5]Lyden P,Pereira B,Chen B,et al.Direct thrombin inhibitor argatroban reduces stroke damage in 2 different models[J].Stroke,2014,45(3):896-899.[6]Sayed A,Munir M,Nabet MS,et al.Galectin-3:A Novel Marker for the Prediction of Stroke Incidence and Clinical Prognosis[J].Mediators Inflamm,2022,2022:2924773.[7]Ramakrishnan P.Could Galectin-3 be a key player in the etiology of neuromyelitis optica spectrum disorder?[J].Med Hypotheses,2021,146:110450.[8]Dong R,Zhang M,Hu Q,et al.Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)[J].Int J Mol Med,2018,41(2):599-614.[9]Appari M,Breitbart A,Brandes F,et al.C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure[J].Circ Res,2017,120(1):66-77.[10]Su H,Yuan Y,Wang XM,et al.Inhibition of CTRP9,a novel and cardiac-abundantly expressed cell survival molecule,by TNFα-initiated oxidative signaling contributes to exacerbated cardiac injury in diabetic mice[J].Basic Res Cardiol,2013,108(1):315.[11]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.[12]Klijn CJ,Paciaroni M,Berge E,et al.Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation:A European Stroke Organisation guideline[J].Eur Stroke J,2019,4(3):198-223.[13]Li G,Fan RM,Chen JL,et al.Neuroprotective effects of argatroban and C5a receptor antagonist (PMX53) following intracerebral haemorrhage[J].Clin Exp Immunol,2014,175(2):285-295.[14]Oguro H,Mitaki S,Takayoshi H,et al.Retrospective Analysis of Argatroban in 353 Patients with Acute Noncardioembolic Stroke[J].J Stroke Cerebrovasc Dis,2018,27(8):2175-2181.[15]Hara A,Niwa M,Noguchi K,et al.Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases[J].Biomolecules,2020,10(3):389.[16]Papaspyridonos M,Mcneill E,De Bono JP,et al.Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction[J].Arterioscler Thromb Vasc Biol,2008,28(3):433-440.[17]Chen X,Lin J,Hu T,et al.Galectin-3 exacerbates ox-LDL-mediated endothelial injury by inducing inflammation via integrin β1-RhoA-JNK signaling activation[J].J Cell Physiol,2019,234(7):10990-11000.[18]Wong GW,Krawczyk SA,Kitidis-Mitrokostas C,et al.Identification and characterization of CTRP9,a novel secreted glycoprotein,from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin[J].FASEB J,2009,23(1):241-258.[19]Yang G,Song Q,Sun C,et al.Ctrp9 and adiponectin receptors in Nile tilapia (Oreochromis niloticus):Molecular cloning,tissue distribution and effects on reproductive genes[J].Gen Comp Endocrinol,2018,265:160-173.[20]Yang Y,Li Y,Ma Z,et al.A brief glimpse at CTRP3 and CTRP9 in lipid metabolism and cardiovascular protection[J].Prog Lipid Res,2016,64:170-177.[21]Shibata R,Ohashi K,Murohara T,et al.The potential of adipokines as therapeutic agents for cardiovascular disease[J].Cytokine Growth Factor Rev,2014,25(4):483-487.[22]Ueki Y,Matsumoto K,Kizaki Y,et al.Argatroban increases nitric oxide levels in patients with peripheral arterial obstructive disease:placebo-controlled study[J].J Thromb Thrombolysis,1999,8(2):131-137.[23]张亮,程立,刘桂花,等.阿加曲班治疗急性脑梗死对患者血管内皮功能Hcy及炎症状态的影响[J].中国实用神经疾病杂志,2017,20(8):17-19.
相似文献/References:
[1]冯 湧.新一代抗凝血药阿加曲班的临床应用进展[J].医学信息,2018,31(02):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
FENG Yong.Progress in Clinical Application of the New Generation Anticoagulant Agatripine[J].Journal of Medical Information,2018,31(23):43.[doi:10.3969/j.issn.1006-1959.2018.02.015]
[2]陈建新.阿加曲班注射液治疗急性脑梗死的疗效及对血清VEGF、GLUT-1水平的影响[J].医学信息,2018,31(19):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
CHEN Jian-xin.Effect of Argatroban Injection on Acute Cerebral Infarction and Its Effect on Serum VEGF and GLUT-1 Levels[J].Journal of Medical Information,2018,31(23):5.[doi:10.3969/j.issn.1006-1959.2018.19.002]
[3]钱朝庆,刘 淼,王家平,等.肾病综合征合并肾静脉血栓应用阿加曲班疗效评价[J].医学信息,2018,31(21):135.[doi:10.3969/j.issn.1006-1959.2018.21.038]
QIAN Chao-qing,LIU Miao,WANG Jia-ping,et al.Clinical Efficacy Evaluation of Argatroban in Nephrotic Syndrome with Renal Vein Thrombosis[J].Journal of Medical Information,2018,31(23):135.[doi:10.3969/j.issn.1006-1959.2018.21.038]
[4]王 英,李彤彤,王 燕,等.替罗非班对急性缺血性卒中大鼠PI3K/Akt/eNOS通路及神经损伤的影响[J].医学信息,2022,35(07):66.[doi:10.3969/j.issn.1006-1959.2022.07.016]
WANG Ying,LI Tong-tong,WANG Yan,et al.Effects of Tirofiban on PI3K/Akt/eNOS Pathway and Nerve Injury in Rats with Acute Ischemic Stroke[J].Journal of Medical Information,2022,35(23):66.[doi:10.3969/j.issn.1006-1959.2022.07.016]
[5]褚春沐.阿加曲班联合阿替普酶静脉溶栓治疗急性脑梗死的效果及对脑血管储备功能的影响[J].医学信息,2022,35(13):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
CHU Chun-mu.Effect of Argatroban Combined with Alteplase Intravenous Thrombolysis on Acute Cerebral Infarction and its Effect on Cerebrovascular Reserve Function[J].Journal of Medical Information,2022,35(23):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
[6]王 杰.阿加曲班对脑梗塞急性期患者血液流变指标及APTT、PT的影响[J].医学信息,2022,35(22):130.[doi:10.3969/j.issn.1006-1959.2022.22.030]
WANG Jie.Effects of Argatroban on Hemorheology Indexes, APTT and PT in Patients with Acute Cerebral Infarction[J].Journal of Medical Information,2022,35(23):130.[doi:10.3969/j.issn.1006-1959.2022.22.030]
[7]赵东慧,王 楠,杨思远.阿加曲班联合阿替普酶静脉溶栓治疗急性脑梗死的疗效及对脑血管储备功能的影响[J].医学信息,2023,36(13):151.[doi:10.3969/j.issn.1006-1959.2023.13.033]
ZHAO Dong-hui,WANG Nan,YANG Si-yuan.Effect of Argatroban Combined with Alteplase Intravenous Thrombolysis on Acute Cerebral Infarction and its Effect on Cerebrovascular Reserve Function[J].Journal of Medical Information,2023,36(23):151.[doi:10.3969/j.issn.1006-1959.2023.13.033]
[8]章违违.心理-生理-社会医学护理模式对急性缺血性卒中患者溶栓舒适度及不良反应的影响[J].医学信息,2024,37(24):186.[doi:10.3969/j.issn.1006-1959.2024.24.049]
ZHANG Weiwei.Effect of Psychological-physiological-social Medical Nursing Model on Thrombolysis Comfort and Adverse Reactions in Patients with Acute Ischemic Stroke[J].Journal of Medical Information,2024,37(23):186.[doi:10.3969/j.issn.1006-1959.2024.24.049]
[9]戴 琦,陈姝彤.急性缺血性卒中血栓异质性的影像学研究进展[J].医学信息,2025,38(02):179.[doi:10.3969/j.issn.1006-1959.2025.02.036]
DAI Qi,CHEN Shutong.Advances in Imaging Research on Thrombosis Heterogeneity in Acute Ischemic Stroke[J].Journal of Medical Information,2025,38(23):179.[doi:10.3969/j.issn.1006-1959.2025.02.036]
[10]郭亚新,石秋艳,王翠兰,等.甘油三酯葡萄糖指数、预后营养指数与急性缺血性卒中的关系研究[J].医学信息,2025,38(05):182.[doi:10.3969/j.issn.1006-1959.2025.05.033]
GUO Yaxin,SHI Qiuyan,WANG Cuilan,et al.Study on the Relationship Between Triglyceride Glucose Index, Prognostic Nutritional Index and Acute Ischemic Stroke[J].Journal of Medical Information,2025,38(23):182.[doi:10.3969/j.issn.1006-1959.2025.05.033]